CanSino Biologics Inc. (688185.SH): DTcP-Hib-MCV4 combination vaccine clinical trial application approved.

16:32 24/02/2025

"Kangxinuo (688185.SH) issued an announcement, stating that the company has recently received the approval and issuance of the National Medical Products Administration on..."

CanSino Biologics Inc. (688185.SH) announced that it recently received the Drug Clinical Trial Approval Notice issued by the National Medical Products Administration for the absorbed cell-free bivalent influenza diphtheria-ACYW135 group meningococcal (conjugate) combined vaccine (referred to as "DTcP-Hib-MCV4 combined vaccine").

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"